113 Botanicals at UK Medical Patient Conference 2023

Medical Cannabis Awareness Week, November 2023: The 2nd annual Patient Conference hosted by Drug Science and the Medcan Family Foundation The UK Patient Conference is open to the general public, created for medical cannabis patients and anyone interested in learning more about cannabis-based medicines with the aim to bridge the gap between cannabis industry and […]

Update:113 Botanicals’ collaboration with University of Sussex

The team at 113 Botanicals are delighted to further extend our research collaboration with the University of Sussex. This collaboration, originally commenced in 2021, has combined our own scientific team with specialist scientists at the University of Sussex and brings together a talented multi-disciplinary team dedicated to progressing research outcomes and to making significant advancements in these […]

113 Botanicals at Cannabis Business Europe 2023, Frankfurt

Cannabis Business Europe 2023, Frankfurt In May, 113 Botanicals was invited to present on the subject of ‘New Product Development in the field of CBMPs’. Tim Kneen, Chief Strategy Officer, gave a in-depth presentation on this topic and received highly positive feedback from the attending industry peers. Tim brings with him vast industry experience and […]

113 Botanicals Joins the Cannabis Industry Council as a Founding Member

May 2021, 113 Botanicals Joins the Cannabis Industry Council as a Founding Member The team at 113 Botanicals are delighted to join the Cannabis Industry Council as one of its founding members. The newly established Cannabis Industry Council was conceived by members of the Executive Committee of the Medical Cannabis Clinicians Society, and is chaired […]

Our Research Collaboration with Bedrocan BV

Research Collaboration with Bedrocan BV We are delighted that our Research team at the University of Sussex will be collaborating with Bedrocan BV, a world-leading producer of APIs within the medicinal cannabis space.In conjunction with their Research and Development teams, the 113 Botanicals team will be using Bedrocan’s high quality APIs to develop further novel […]

113 Botanicals Research Programme with the University of Sussex

Extending Our Research Programme with the University of Sussex Our research collaboration with the University of Sussex commenced in June 2020 with the opening of our dedicated laboratory within the School of Life Sciences. After extensive preparation by the team, we successfully gained our Schedule 1 controlled drugs licence in February 2021.113 Botanicals is delighted […]

Our Research Collaboration with Lab Ofichem

Our Research Collaboration with Lab Ofichem As part of our continued synergistic work with world-leading organisations in the European medicinal cannabis industry, we are proud to confirm our collaborative research partnership with the Netherlands based Lab Ofichem, part of the Ofichem Group. Working in conjunction with their R&D and Technical Innovation departments, and using their […]

113 Botanicals Limited Successfully Gains Schedule 1 Controlled Drugs Licence

113 Botanicals Limited Successfully Gains Schedule 1 Controlled Drugs Licence After many months of detailed preparation work (and despite the many challenges presented by the pandemic), the onsite collaboration started in June 2020 with the opening of our dedicated laboratory within The School of Life Sciences at The University of Sussex. The remit of the […]